A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1.
about
Predictive value of BRCA1 expression on the efficacy of chemotherapy based on anti-microtubule agents: a pooled analysis across different malignancies and agentsTumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapyFine tuning chemotherapy to match BRCA1 statusTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerResistance to paclitaxel in a cisplatin-resistant ovarian cancer cell line is mediated by P-glycoproteinDistinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancerCurcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKβ protein of the NFκB pathwayBiomarkers for prognosis and treatment selection in advanced bladder cancer patients.Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis.Personalized therapy for urothelial cancer: review of the clinical evidence.Tumour suppressor genes in chemotherapeutic drug response.Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancersCyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma.Distinct genetic alterations occur in ovarian tumor cells selected for combined resistance to carboplatin and docetaxelBRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.Novel strategies for reversing platinum resistance.The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.A Human Head and Neck Squamous Cell Carcinoma Cell Line with Acquired cis-Diamminedichloroplatinum-Resistance Shows Remarkable Upregulation of BRCA1 and Hypersensitivity to Taxane.MiRNAs-mediated cisplatin resistance in breast cancer.MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1.Dual-pore mesoporous carbon@silica composite core-shell nanospheres for multidrug delivery.Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial CarcinomaAnalysis of resistance-associated gene expression in docetaxel-resistant prostate cancer cells.[Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing gene 1 in lung cancer cell A549/DDP].CD10-/ALDH- cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchy.Sophoraflavanone G Induces Apoptosis in Human Leukemia Cells and Blocks MAPK Activation.[Advances of DNA damage repair and Cisplatin resistance mechanisms in lung cancer].
P2860
Q26748931-AA167A9A-BD86-486F-8C27-3267CBD724D3Q26768521-3817CAEE-9064-41DA-A40F-B483E08DCD3FQ27694529-854F4DE4-1074-49BE-971D-2D81F5BDD576Q28396304-939FBF7B-96DE-4808-AF84-9552F704431CQ28481246-8BC4ECB0-1953-41E1-9CF0-CF4876F0D163Q33704050-0E5350A4-E0ED-4C5A-A310-09ABC1CA46D1Q34415256-4D66E34D-428D-40CB-A9F3-0792039D23EDQ35671292-6C5AF458-465C-44EC-A31D-58364220BABBQ36020872-10812609-598D-4FEA-90CD-F94691E94EAAQ36062762-EBBE452F-CE33-47D4-B074-70BAF6198E95Q36083098-250AFAC3-DF27-4274-8D19-8F8541050195Q36356952-E6745B17-2580-4913-AAC6-8EBCA9A572FAQ36424035-54CBF427-CCCA-4272-AFAD-54347FDC36DEQ36521792-AA1C26AC-6F27-483C-A59A-91458EDD5D59Q36747377-73E69C53-0016-443B-90D4-72962046F0CBQ37461061-35723D20-BA65-405A-8582-0679C2A1FF7DQ37983690-5E58F237-255D-4FBE-94FF-B62E252D9F84Q38791316-5217C110-8B83-408A-B34E-D73B47F21395Q38905681-BB264EB1-4EB4-4F73-B15E-471D87982B84Q38940572-A044C175-665E-408C-8B46-B2F86732F61DQ39001339-8039B8F5-D61E-4E94-A102-3893B6C8CE0BQ41002840-AAD15871-9E47-4CCA-909B-8557F49A2AD0Q41611182-FF85B172-7848-48FB-B39D-74A905030453Q42907465-1B3D67CD-386A-49F6-A840-5E73FC1D3D0FQ45046872-239C7126-B744-4F8D-88CD-F4872E179EBAQ51304468-07A93B74-AF0F-42E3-A860-C03B8450FEEAQ55434155-0B46E7D7-3CB0-4182-871C-A36677C3D03D
P2860
A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A systematic review of genes i ...... l chemotherapy: role of BRCA1.
@en
A systematic review of genes i ...... l chemotherapy: role of BRCA1.
@nl
type
label
A systematic review of genes i ...... l chemotherapy: role of BRCA1.
@en
A systematic review of genes i ...... l chemotherapy: role of BRCA1.
@nl
prefLabel
A systematic review of genes i ...... l chemotherapy: role of BRCA1.
@en
A systematic review of genes i ...... l chemotherapy: role of BRCA1.
@nl
P1476
A systematic review of genes i ...... l chemotherapy: role of BRCA1.
@en
P2093
Britta Stordal
Ross Davey
P304
P356
10.2174/156800909788166592
P577
2009-05-01T00:00:00Z